These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17279347)

  • 1. Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.
    Fenili D; Brown M; Rappaport R; McLaurin J
    J Mol Med (Berl); 2007 Jun; 85(6):603-11. PubMed ID: 17279347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's Disease.
    Morrone CD; Thomason LA; Brown ME; Aubert I; McLaurin J
    PLoS One; 2016; 11(10):e0165393. PubMed ID: 27768761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of a cyclitol-derived scaffold with axial pyridyl appendages and its encapsulation of the silver(I) cation.
    Léo PM; Morin C; Philouze C
    Beilstein J Org Chem; 2010 Oct; 6():1022-4. PubMed ID: 21085514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease.
    Ma K; Thomason LA; McLaurin J
    Adv Pharmacol; 2012; 64():177-212. PubMed ID: 22840748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
    Sevigny J; Chiao P; Bussière T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; O'Gorman J; Qian F; Arastu M; Li M; Chollate S; Brennan MS; Quintero-Monzon O; Scannevin RH; Arnold HM; Engber T; Rhodes K; Ferrero J; Hang Y; Mikulskis A; Grimm J; Hock C; Nitsch RM; Sandrock A
    Nature; 2016 Sep; 537(7618):50-6. PubMed ID: 27582220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for Alzheimer's disease in clinical trials.
    Godyń J; Jończyk J; Panek D; Malawska B
    Pharmacol Rep; 2016 Feb; 68(1):127-38. PubMed ID: 26721364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.
    Salloway S; Sperling R; Keren R; Porsteinsson AP; van Dyck CH; Tariot PN; Gilman S; Arnold D; Abushakra S; Hernandez C; Crans G; Liang E; Quinn G; Bairu M; Pastrak A; Cedarbaum JM;
    Neurology; 2011 Sep; 77(13):1253-62. PubMed ID: 21917766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer's Disease.
    André S; Verteneuil S; Ris L; Kahvecioglu ZC; Nonclercq D; De Winter J; Vander Elst L; Laurent S; Muller RN; Burtea C
    J Alzheimers Dis Rep; 2023; 7(1):1395-1426. PubMed ID: 38225969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting NF-κB pathway for the anti-inflammatory potential of Bhadradarvadi kashayam on stimulated RAW 264.7 macrophages.
    Ali A M MT; Narayana S DS; Lulu S S; Nag S; Sundararajan V
    Heliyon; 2023 Aug; 9(8):e19270. PubMed ID: 37664699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclitols: From Basic Understanding to Their Association with Neurodegeneration.
    Derkaczew M; Martyniuk P; Osowski A; Wojtkiewicz J
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuzzy Drug Targets: Disordered Proteins in the Drug-Discovery Realm.
    Saurabh S; Nadendla K; Purohit SS; Sivakumar PM; Cetinel S
    ACS Omega; 2023 Mar; 8(11):9729-9747. PubMed ID: 36969402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid Disassembly: What Can We Learn from Chaperones?
    Almeida ZL; Brito RMM
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36552032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive glucose dehydrogenase elevates intracellular NADPH levels and luciferase luminescence in Bacillus subtilis.
    Wu Y; Kawabata H; Kita K; Ishikawa S; Tanaka K; Yoshida KI
    Microb Cell Fact; 2022 Dec; 21(1):266. PubMed ID: 36539761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule drugs development for Alzheimer's disease.
    Yao W; Yang H; Yang J
    Front Aging Neurosci; 2022; 14():1019412. PubMed ID: 36389082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Effects of Developmental Exposure to Oxycodone on Gut Microbiota and Relationship to Adult Behaviors and Metabolism.
    Lyu Z; Schmidt RR; Martin RE; Green MT; Kinkade JA; Mao J; Bivens NJ; Joshi T; Rosenfeld CS
    mSystems; 2022 Aug; 7(4):e0033622. PubMed ID: 35862801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer's Disease.
    Xiao M; Xiang W; Chen Y; Peng N; Du X; Lu S; Zuo Y; Li B; Hu Y; Li X
    Front Nutr; 2022; 9():852433. PubMed ID: 35782939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics Approach Explore Diagnostic Biomarkers and Metabolic Changes in Heat-Stressed Dairy Cows.
    Yue S; Ding S; Zhou J; Yang C; Hu X; Zhao X; Wang Z; Wang L; Peng Q; Xue B
    Animals (Basel); 2020 Sep; 10(10):. PubMed ID: 32992834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases.
    López-Gambero AJ; Sanjuan C; Serrano-Castro PJ; Suárez J; Rodríguez de Fonseca F
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32825356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further understanding the connection between Alzheimer's disease and Down syndrome.
    Snyder HM; Bain LJ; Brickman AM; Carrillo MC; Esbensen AJ; Espinosa JM; Fernandez F; Fortea J; Hartley SL; Head E; Hendrix J; Kishnani PS; Lai F; Lao P; Lemere C; Mobley W; Mufson EJ; Potter H; Zaman SH; Granholm AC; Rosas HD; Strydom A; Whitten MS; Rafii MS
    Alzheimers Dement; 2020 Jul; 16(7):1065-1077. PubMed ID: 32544310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
    Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
    Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.